Mylan Pushes Back Against EpiPen Buyers' Appeal Bid
Mylan urged a Kansas federal judge to dismiss a class of EpiPen buyers' bid to appeal a June order finding that the drug giant cannot face racketeering allegations or claims over...To view the full article, register now.
Already a subscriber? Click here to view full article